Abstract
Inflammation has been implicated in the development of various psychiatric disorders, including depression. However, the neurobehavioral mechanism involved in this relationship remains elusive. This gap in knowledge may best be filled by evaluating elementary neurobehavioral units affected by inflammation rather than behavioral changes in conventional animal tests of depression. To this end, the current study used a concurrent choice paradigm to evaluate inflammation-induced motivational changes. Male C57BL/6J mice (n=27) were food restricted to between 85 and 90% of their free-feeding weight and were trained to perform a concurrent choice task where they nose-poked for grain rewards on a fixed ratio (FR) 1 schedule (low effort/low reward) and chocolate-flavored rewards on a FR-10 schedule (high effort/high reward). A counterbalanced-within subjects design was used. A single intraperitoneal injection of 0.33 mg/kg lipopolysaccharide (LPS) was used to induce peripheral inflammation. Twenty-four hours after LPS administration, mice showed a reduction in the total number of nose pokes. A proportionally greater reduction in nose pokes was observed for grain, resulting in an increase in percent chocolate pellets earned. These behavioral changes cannot be explained by reduced appetite as feeding before the test led to a similar increase in percent chocolate pellets earned but without any decrease in responding. These results indicate that inflammation modulates incentive motivation by affecting willingness to exert effort for reward and not by reducing sensitivity to reward.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Angeles-Castellanos M, Salgado-Delgado R, Rodriguez K, Buijs RM, Escobar C (2008). Expectancy for food or expectancy for chocolate reveals timing systems for metabolism and reward. Neuroscience 155: 297–307.
Anisman H, Kokkinidis L, Borowski T, Merali Z (1998). Differential effects of interleukin (IL)-1β, IL-2 and IL-6 on responding for rewarding lateral hypothalamic stimulation. Brain Res 779: 177–187.
Asarian L, Langhans W (2010). A new look on brain mechanisms of acute illness anorexia. Physiol Behav 100: 464–471.
Aubert A (1999). Sickness and behaviour in animals: a motivational perspective. Neurosci Biobehav Rev 23: 1029–1036.
Aubert A, Dantzer R (2005). The taste of sickness: lipopolysaccharide-induced finickiness in rats. Physiol Behav 84: 437–444.
Aubert A, Goodall G, Dantzer R, Gheusi G (1997). Differential effects of lipopolysaccharide on pup retrieving and nest building in lactating mice. Brain Behav Immun 11: 107–118.
Berridge KC (1996). Food reward: brain substrates of wanting and liking. Neurosci Biobehav Rev 20: 1–25.
Berridge KC (2009). ‘Liking’and ‘wanting’food rewards: brain substrates and roles in eating disorders. Physiol Behav 97: 537–550.
Borowski T, Kokkinidis L, Merali Z, Anisman H (1998). Lipopolysaccharide, central in vivo biogenic amine variations, and anhedonia. Neuroreport 9: 3797–3802.
Capuron L, Pagnoni G, Drake DF, Woolwine BJ, Spivey JR, Crowe RJ et al (2012). Dopaminergic mechanisms of reduced basal ganglia responses to hedonic reward during interferon alfa administrationreduced basal ganglia responses to hedonic reward. Arch Gen Psychiatry 69: 1044–1053.
Cousins MS, Wei W, Salamone JD (1994). Pharmacological characterization of performance on a concurrent lever pressing/feeding choice procedure: effects of dopamine antagonist, cholinomimetic, sedative and stimulant drugs. Psychopharmacology (Berl) 116: 529–537.
Cross-Mellor SK, Kavaliers M, Ossenkopp K-P (2004). Comparing immune activation (lipopolysaccharide) and toxin (lithium chloride)-induced gustatory conditioning: lipopolysaccharide produces conditioned taste avoidance but not aversion. Behavi Brain Res 148: 11–19.
Cross-Mellor SK, Kent WD, Kavaliers M, Ossenkopp K-P (2000). Examining the effects of lipopolysaccharide and cholecystokinin on water ingestion: comparing intake and palatability. Brain Res 861: 220–232.
Cross-Mellor SK, Kent WD, Ossenkopp K-P, Kavaliers M (1999). Differential effects of lipopolysaccharide and cholecystokinin on sucrose intake and palatability. Am J Physiol 277: R705–R715.
Cuthbert BN, Insel TR (2010). Toward new approaches to psychotic disorders: the NIMH research domain criteria project. Schizophr Bull 36: 1061–1062.
Dantzer R (2001). Cytokine-induced sickness behavior: where do we stand? Brain Behav Immun 15: 7–24.
Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW (2008). From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9: 46–56.
Deminiere JM, Piazza PV, Le Moal M, Simon H (1989). Experimental approach to individual vulnerability to psychostimulant addiction. Neurosci Biobehav Rev 13: 141–147.
Eisenberger NI, Berkman ET, Inagaki TK, Rameson LT, Mashal NM, Irwin MR (2010). Inflammation-induced anhedonia: endotoxin reduces ventral striatum responses to reward. Biol Psychiatry 68: 748–754.
Farrar A, Segovia K, Randall P, Nunes EJ, Collins LE, Stopper CM et al (2010). Nucleus accumbens and effort-related functions: behavioral and neural markers of the interactions between adenosine A< sub> 2A</sub> and dopamine D< sub> 2</sub> receptors. Neuroscience 166: 1056–1067.
Felger JC, Miller AH (2012). Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise. Front Neuroendocrinol 33: 315–327.
Frenois F, Moreau M, O'Connor J, Lawson M, Micon C, Lestage J et al (2007). Lipopolysaccharide induces delayed FosB/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior. Psychoneuroendocrinology 32: 516–531.
Johnson AW, Gallagher M (2011). Greater effort boosts the affective taste properties of food. Proc R Soc B 278: 1450–1456.
Kamata M, Higuchi H, Yoshimoto M, Yoshida K, Shimizu T (2000). Effect of single intracerebroventricular injection of α-interferon on monoamine concentrations in the rat brain. Eur Neuropsychopharmacol 10: 129–132.
Kitagami T, Yamada K, Miura H, Hashimoto R, Nabeshima T, Ohta T (2003). Mechanism of systemically injected interferon-alpha impeding monoamine biosynthesis in rats: role of nitric oxide as a signal crossing the blood–brain barrier. Brain Res 978: 104–114.
Langhans W (1996). Bacterial products and the control of ingestive behavior: clinical implications. Nutrition 12: 303–315.
Larson SJ (2006). Lipopolysaccharide and interleukin-1β decrease sucrose intake but do not affect expression of place preference in rats. Pharmacol Biochem Behav 84: 429–435.
Larson SJ, Romanoff RL, Dunn AJ, Glowa JR (2002). Effects of interleukin-1β on food-maintained behavior in the mouse. Brain Behav Immun 16: 398–410.
Leboyer M, Soreca I, Scott J, Frye M, Henry C, Tamouza R et al (2012). Can bipolar disorder be viewed as a multi-system inflammatory disease? J Affect Disord 141: 1–10.
Merali Z, Brennan K, Brau P, Anisman H (2003). Dissociating anorexia and anhedonia elicited by interleukin-1β: antidepressant and gender effects on responding for “free chow “and earned” sucrose intake. Psychopharmacology (Berl) 165: 413–418.
Miller AH, Maletic V, Raison CL (2009). Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 65: 732–741.
Miller NE (1964). Some psychophysiological studies of motivation and of the behavioural effects of illness. Bull Brit Psychol Soc 17: 1271–1278.
Mitchell MR, Weiss VG, Beas BS, Morgan D, Bizon JL, Setlow B (2014). Adolescent risk taking, cocaine self-administration, and striatal dopamine signaling. Neuropsychopharmacology 39: 955–962.
Nunes EJ, Randall PA, Estrada A, Epling B, Hart EE, Lee CA et al (2013). Effort-related motivational effects of the pro-inflammatory cytokine interleukin 1-beta: studies with the concurrent fixed ratio 5/chow feeding choice task. Psychopharmacology (Berl) 231: 727–736.
O'Connor JC, André C, Wang Y, Lawson MA, Szegedi SS, Lestage J et al (2009a). Interferon-γ and tumor necrosis factor-α mediate the upregulation of indoleamine 2, 3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guérin. J Neurosci 29: 4200–4209.
O'Connor JC, Lawson MA, André C, Briley EM, Szegedi SS, Lestage J et al (2009b). Induction of IDO by bacille Calmette-Guerin is responsible for development of murine depressive-like behavior. J Immunol 182: 3202–3212.
O'Connor JC, Lawson MA, Andre C, Moreau M, Lestage J, Castanon N et al (2009c). Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry 14: 511–522.
Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, Kouassi E (2008). Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry 63: 801–808.
Randall PA, Pardo M, Nunes EJ, Lopez Cruz L, Vemuri VK, Makriyannis A et al (2012). Dopaminergic modulation of effort-related choice behavior as assessed by a progressive ratio chow feeding choice task: pharmacological studies and the role of individual differences. PloS one 7: e47934.
Salamone JD, Correa M, Farrar A, Mingote SM (2007). Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits. Psychopharmacology (Berl) 191: 461–482.
Salamone JD, Steinpreis RE, McCullough LD, Smith P, Grebel D, Mahan K (1991). Haloperidol and nucleus accumbens dopamine depletion suppress lever pressing for food but increase free food consumption in a novel food choice procedure. Psychopharmacology (Berl) 104: 515–521.
Shen Y, Connor TJ, Nolan Y, Kelly JP, Leonard BE (1999). Differential effect of chronic antidepressant treatments on lipopolysaccharide-induced depressive-like behavioural symptoms in the rat. Life Sci 65: 1773–1786.
Shuto H, Kataoka Y, Horikawa T, Fujihara N, Oishi R (1997). Repeated interferon-α administration inhibits dopaminergic neural activity in the mouse brain. Brain Res 747: 348–351.
Taylor RR, Kielhofner GW (2003). An occupational therapy approach to persons with chronic fatigue syndrome: part two, assessment and intervention. Occup Ther Health Care 17: 63–87.
Treadway MT, Bossaller NA, Shelton RC, Zald DH (2012). Effort-based decision-making in major depressive disorder: a translational model of motivational anhedonia. J Abnorm Psychol 121: 553–558.
Treadway MT, Buckholtz JW, Schwartzman AN, Lambert WE, Zald DH (2009). Worth the 'EEfRT'? the effort expenditure for rewards task as an objective measure of motivation and anhedonia. PloS one 4: e6598.
Wakamatsu H, Yoshinobu Y, Aida R, Moriya T, Akiyama M, Shibata S (2001). Restricted-feeding-induced anticipatory activity rhythm is associated with a phase-shift of the expression of mPer1 and mPer2 mRNA in the cerebral cortex and hippocampus but not in the suprachiasmatic nucleus of mice. Eur J Neurosci 13: 1190–1196.
Walker AK, Budac DP, Bisulco S, Lee AW, Smith RA, Beenders B et al (2013). NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL/6J Mice. Neuropsychopharmacology 38: 1609–1616.
Yamamura Y, Yano I, Kudo T, Shibata S (2010). Time-dependent inhibitory effect of lipopolysaccharide injection on Per1 and Per2 gene expression in the mouse heart and liver. Chronobiol Int 27: 213–232.
Yirmiya R (1996). Endotoxin produces a depressive-like episode in rats. Brain Res 711: 163–174.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vichaya, E., Hunt, S. & Dantzer, R. Lipopolysaccharide Reduces Incentive Motivation While Boosting Preference for High Reward in Mice. Neuropsychopharmacol 39, 2884–2890 (2014). https://doi.org/10.1038/npp.2014.141
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/npp.2014.141
This article is cited by
-
Sick for science: experimental endotoxemia as a translational tool to develop and test new therapies for inflammation-associated depression
Molecular Psychiatry (2021)
-
Lipopolysaccharide does not alter behavioral response to successive negative contrast in mice
Psychopharmacology (2021)
-
Interactions between Motivational and Discriminative Functions of Motivating Operations in the Renewal of Operant Responding in Mice
The Psychological Record (2020)
-
Motivational changes that develop in a mouse model of inflammation-induced depression are independent of indoleamine 2,3 dioxygenase
Neuropsychopharmacology (2019)
-
Effort but not Reward Sensitivity is Altered by Acute Sickness Induced by Experimental Endotoxemia in Humans
Neuropsychopharmacology (2018)
